NEOSH101
NEOSH101 is a topical solution made by Neosil, Inc. that shows great promise as a breakthrough future treatment for hair loss. The active ingredient in the topical solution is called Tetrapeptide Aldehyde Proteasome Inhibibitor. This substance is applied directly to the scalp and it stimulates the hair follicle to produce hair.
Neosil, Inc. has been in the process of conducting 2 clinical trials in Germany. Two studies were being performed, which both started in 2007. One was evaluating the general efficacy and safety of the drug and the other was evaluating efficacy and safety of the drug at different doses. NEOSH101 was applied once daily for 16 weeks. Initial results show significant increases in thickness, rate of growth, and the amount of hair growth. In addition, there are no observed side effects as of yet.
This website was recently told that the clinical trials on the drug are on hold. However the company continues to work on the science behind the treatment. The reason for putting the clinical trials on hold relates to limited financial resources and the allocation of funds to other products being researched. Of the two studies that were started 2007, we believe one was completed showing good positive results. We are unsure about the other. We will keep you updated on NEOSH101 as we receive updated information, so stay tuned.
Neosil’s parent company is Peplin, Inc. Neosil doesn’t have its own website, but any updates on NEOSH101 will be posted on Peplin’s website
Click here to visit Peplin's website
